tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Steve Mcgarry, 2 are a HOLD (50%), 2 are a BUY (50%).
Analyst Steve Mcgarry works at HSBC with a stock forecast success ratio of 27.78% fulfilled within 207.67 days on average.
Steve Mcgarry’s has documented 13 price targets and ratings displayed on 3 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on GSK, GlaxoSmithKline PLC ADR at 18-Feb-2022.
Analyst best performing recommendations are on GSK (GLAXOSMITHKLINE PLC ADR).
The best stock recommendation documented was for GSK (GLAXOSMITHKLINE PLC ADR) at 2/18/2022. The price target of $29.46 was fulfilled within 210 days with a profit of $10.9 (27.01%) receiving and performance score of 1.29.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
44
$3.15 (7.71%)
18.72
2 months 28 days ago
0/14 (0%)
$5.1 (13.11%)
Buy
48
$7.15 (17.50%)
39
3 months 17 days ago
1/3 (33.33%)
$9.46 (24.55%)
265
Hold
19.52
$-21.33 (-52.22%)
18.9
8 months 6 days ago
0/3 (0%)
$-14.87 (-43.24%)
Hold
19.58
$-22.45 (-53.41%)
19.96
11 months 30 days ago
0/2 (0%)
$-16.05 (-45.05%)
Buy
21.66
1 years 1 months 3 days ago
0/13 (0%)
$-19.7 (-47.63%)
What Year was the first public recommendation made by Steve Mcgarry?
